Study aims to spare breast cancer patients from chemotherapy
NCT ID NCT07428018
Summary
This study is testing if some patients with a common type of early breast cancer can avoid chemotherapy before surgery. Instead, they would receive a targeted pill (abemaciclib) plus hormone therapy. The goal is to see if this gentler approach works as well for shrinking tumors, potentially allowing for less extensive surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Istituto di Ricerche Farmacologiche Mario Negri IRCCS
Milan, MI, 20156, Italy
Conditions
Explore the condition pages connected to this study.